219 related articles for article (PubMed ID: 21081500)
1. Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
Im SS; Kim MY; Kwon SK; Kim TH; Bae JS; Kim H; Kim KS; Oh GT; Ahn YH
J Biol Chem; 2011 Jan; 286(2):1157-64. PubMed ID: 21081500
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
[TBL] [Abstract][Full Text] [Related]
3. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
4. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.
Xu J; Xiao G; Trujillo C; Chang V; Blanco L; Joseph SB; Bassilian S; Saad MF; Tontonoz P; Lee WN; Kurland IJ
J Biol Chem; 2002 Dec; 277(52):50237-44. PubMed ID: 12176975
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gluconeogenic genes by calcium-regulated heat-stable protein 1 via repression of peroxisome proliferator-activated receptor α.
Fan Y; Guo Y; Hamblin M; Chang L; Zhang J; Chen YE
J Biol Chem; 2011 Nov; 286(47):40584-94. PubMed ID: 21990353
[TBL] [Abstract][Full Text] [Related]
7. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
Qiao L; MacLean PS; You H; Schaack J; Shao J
Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
[TBL] [Abstract][Full Text] [Related]
8. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
[TBL] [Abstract][Full Text] [Related]
9. Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver.
Haase TN; Ringholm S; Leick L; Biensø RS; Kiilerich K; Johansen S; Nielsen MM; Wojtaszewski JF; Hidalgo J; Pedersen PA; Pilegaard H
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1501-9. PubMed ID: 21832205
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
11. Regulation of IGFBP-2 expression during fasting.
Kang HS; Kim MY; Kim SJ; Lee JH; Kim YD; Seo YK; Bae JH; Oh GT; Song DK; Ahn YH; Im SS
Biochem J; 2015 May; 467(3):453-60. PubMed ID: 25695641
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model.
Savas Ü; Machemer DEW; Hsu MH; Gaynor P; Lasker JM; Tukey RH; Johnson EF
J Biol Chem; 2009 Jun; 284(24):16541-16552. PubMed ID: 19366684
[TBL] [Abstract][Full Text] [Related]
13. Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells.
Xu H; Yang Q; Shen M; Huang X; Dembski M; Gimeno R; Tartaglia LA; Kapeller R; Wu Z
J Biol Chem; 2005 Oct; 280(43):36013-8. PubMed ID: 16126724
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.
Li X; Xu M; Wang F; Kohan AB; Haas MK; Yang Q; Lou D; Obici S; Davidson WS; Tso P
J Biol Chem; 2014 Jan; 289(4):2396-404. PubMed ID: 24311788
[TBL] [Abstract][Full Text] [Related]
15. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
16. Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB).
Xiao F; Deng J; Jiao F; Hu X; Jiang H; Yuan F; Chen S; Niu Y; Jiang X; Guo F
FASEB J; 2022 Oct; 36(10):e22541. PubMed ID: 36083102
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
18. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
19. Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line.
Li X; Xu M; Wang F; Ji Y; DavidsoN WS; Li Z; Tso P
PLoS One; 2015; 10(11):e0142098. PubMed ID: 26556724
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]